Cell Therapeutics (CTIC)
Cell Therapeutics Times Interest Earned TTM: -86.08
View CTIC Times Interest Earned TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CTIC Times Interest Earned TTM Rankings
| Overall | 4th percentile | 2916 of 3051 |
| Sector | 15th percentile | 298 of 352 in Healthcare |
| Industry | 28th percentile | 70 of 98 in Biotechnology |
CTIC Times Interest Earned TTM Range, Past 5 Years
| Minimum | -86.08 | Mar 2012 |
| Maximum | -1.550 | Mar 2009 |
| Average | -26.89 |
About Times Interest Earned (TTM)
Also known as the "Interest Coverage Ratio."
Times interest earned is a key metric to determine the credit worthiness of a business. Essentially, the number represents how many times the last 12 months' EBIT (earnings before interest and taxes) would have covered the past 12 months' interest expenses.
This ratio works well when looking at manufacturing businesses, utilities, and certain service businesses. It should be used with care when analyzing financial service companies because their business models borrow differently from traditional manufacturing and service businesses.
Learn More
You may also be interested in these CTIC related companies
CTIC News
CellTherapeutics (CTIC) Gets Conditional EC Marketing Authorization for Pixuvri
May 11, 9:14AM Street Insider
May 11, 9:14AM Street Insider
Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
Apr 20, 1:30AM PR Newswire
Apr 20, 1:30AM PR Newswire
Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Apr 19, 8:00PM PR Newswire
Apr 19, 8:00PM PR Newswire
Cell Therapeutics (CTIC) to Acquire Rights on S*BIO's Pacritinib JAK2 Inhibitor
Apr 19, 6:54AM Street Insider
Apr 19, 6:54AM Street Insider
Cell Therapeutics, Inc. (CTI) to Host Conference Call April 19, 8:30 AM ET
Apr 18, 8:00PM PR Newswire
Apr 18, 8:00PM PR Newswire
Cell Therapeutics and Keryx Biopharmaceuticals Hope for Help From the TREAT Act
Mar 22, 8:20AM Marketwire
Mar 22, 8:20AM Marketwire
Cell Therapeutics and Avanir Pharmaceuticals Look to Make Headway in Strengthening Biotech Industry
Mar 12, 8:20AM Marketwire
Mar 12, 8:20AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CTIC | 0.91 | -0.01 | -1.09% | 206.22M |
| CRS | 46.44 | -1.12 | -2.35% | 2.373B |
| CRRC | 10.48 | +0.44 | +4.38% | 128.38M |
| CRRB | 5.38 | -0.03 | -0.55% | 13.88M |
| CRR | 82.79 | -1.50 | -1.78% | 1.911B |
| CROX | 17.44 | +0.35 | +2.05% | 1.567B |
| CRNT | 8.42 | -0.04 | -0.47% | 296.97M |
| CRMT | 41.34 | -3.68 | -8.17% | 396.45M |
| CRME | 0.44 | +0.01 | +2.33% | 26.90M |
| CRMD | 0.27 | -0.01 | -3.50% | 3.081M |
